Ternary Tx Managed by: Oliver Sexton
2 known investors
Ternary Therapeutics designs small molecule drugs called molecular glues using AI and physics-based modeling to enable protein interactions for treating diseases including cancer and arthritis. The company applies machine learning to structure-based drug discovery, addressing the geometric constraints of rational drug design.
AI & Machine LearningBiotechDeep Tech